Time for you.

TASCENSO ODT® is a multiple sclerosis (MS) treatment with your needs in mind. It is the same proven fingolimod you might be familiar with, but it comes in a unique orally disintegrating tablet (ODT) formulation1, accompanied by Cycle Vita, our dedicated support platform.

It is a prescription medicine used to treat relapsing forms of MS, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.1

Find out more

NOT ACTUAL PATIENT

Tascenso Care Icon

Support

We know that life-changing treatments need a support system which is tailored to the unique challenges you might be facing. That’s why we created Cycle Vita, our dedicated hub support program, which delivers individualized product support* at every step. Including:

Find out more
Tascenso Dissolve Icon

Product

TASCENSO ODT is the same proven fingolimod you might be familiar with, but it comes in a unique orally disintegrating tablet formulation.1

  • Unique orally disintegrating tablet for MS treatment
  • Same proven fingolimod
  • Same efficacy & safety as Gilenya®
  • Not a generic²
  • Not substitutable at the pharmacy level²
  • Dissolves on the tongue in seconds
  • Once daily, with or without food, with or without water
  • Available as 0.25 mg and 0.5 mg orally disintegrating tablets
  • Every batch tested and verified
Find out more

References

1. TASCENSO ODT (fingolimod). Prescribing Information. Cycle Pharmaceuticals Ltd.

2. FDA., 2023. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Accessed April 25th 2023. Available: https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm

*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at +1 (888) 360-8482.

Gilenya® is a registered trademark of Novartis AG.